|
PTPRA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.015200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.824000E-01 |
| Normal-vs-Stage2 |
9.595600E-01 |
| Normal-vs-Stage3 |
6.830600E-01 |
| Normal-vs-Stage4 |
7.440400E-02 |
| Stage1-vs-Stage2 |
8.804600E-01 |
| Stage1-vs-Stage3 |
8.489000E-01 |
| Stage1-vs-Stage4 |
1.334020E-01 |
| Stage2-vs-Stage3 |
7.917000E-01 |
| Stage2-vs-Stage4 |
1.656410E-01 |
| Stage3-vs-Stage4 |
1.443970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.885200E-01 |
| Normal-vs-AfricanAmerican |
8.648800E-01 |
| Normal-vs-Asian |
5.194800E-01 |
| Caucasian-vs-AfricanAmerican |
4.488000E-01 |
| Caucasian-vs-Asian |
6.210000E-01 |
| AfricanAmerican-vs-Asian |
7.760800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.304200E-01 |
| Normal-vs-Female |
4.277700E-03 |
| Male-vs-Female |
5.989900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.290200E-01 |
| Normal-vs-Extreme_Weight |
7.658000E-01 |
| Normal-vs-Obese |
3.563000E-01 |
| Normal-vs-Extreme_Obese |
4.327800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.347800E-01 |
| Normal_Weight-vs-Obese |
3.209800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.768600E-01 |
| Extreme_Weight-vs-Obese |
2.998400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.579000E-01 |
| Obese-vs-Extreme_Obese |
2.691600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.469800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.237640E-01 |
| Normal-vs-Age(61-80Yrs) |
5.674400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.625900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.104600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.967610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.931900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.563600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.065690E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.597000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.641600E-01 |
| Normal-VS-Type2 PRCC |
2.005700E-02 |
| Normal-VS-KIRP CIMP |
5.310400E-01 |
| Normal-VS-Unclassified PRCC |
3.262300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.836560E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.482200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.410000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.897700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.439300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.296800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.690400E-01 |
| Normal-vs-N1 |
7.061800E-01 |
| Normal-vs-N2 |
8.274800E-01 |
| N0-vs-N1 |
6.302800E-01 |
| N0-vs-N2 |
8.074000E-01 |
| N1-vs-N2 |
9.757000E-01 |
|
|
